Supporting Implementation of Sustainable Blood Safety Activities in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 154502CONT16

Opportunity Information: Apply for CDC RFA GH15 154502CONT16

Supporting Implementation of Sustainable Blood Safety Activities in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) is a Centers for Disease Control and Prevention (CDC) funding opportunity designed to continue and reinforce work that strengthens blood safety systems in Kenya. The program sits within PEPFAR, which is the US government initiative focused on controlling the HIV epidemic, and the emphasis here is on keeping blood transfusions safe, reliable, and sustainable as part of broader public health and HIV prevention efforts. The activity category is health, and the award is structured as a cooperative agreement, meaning CDC is expected to have substantial involvement in the technical direction, oversight, and collaboration with the funded organization rather than providing a hands-off grant.

This particular announcement is not a new open competition. It is explicitly labeled as a continuation opportunity, and the description makes clear that the funds are intended only for organizations that were previously awarded under the earlier solicitation CDC-RFA-GH15-1545. In other words, eligibility is effectively limited to existing grantees already implementing the blood safety work in Kenya under that prior award. The listing shows the eligible applicant type as "Others," but the continuation language signals that the real gatekeeping factor is prior award status, not a broad applicant pool.

The opportunity is identified by the number CDC RFA GH15 154502CONT16 and is associated with CFDA 93.067, which is one of CDC's public health assistance program identifiers. The original closing date shown is December 2, 2015, with a creation date of October 1, 2015, which fits the typical pattern for a continuation or amendment posting that supports an already active project. The award ceiling is listed as 0 and the expected number of awards is left blank, which commonly indicates that the posting is not trying to advertise a competitive maximum budget or attract multiple new applicants; instead, it is documenting the administrative mechanism to continue funding within an existing project framework.

In practical terms, the focus implied by the title and PEPFAR context is sustaining blood safety activities that reduce transfusion-transmitted infections and strengthen the national blood system. This can include support for voluntary non-remunerated blood donation systems, donor recruitment and retention strategies, quality management systems for blood services, improved screening and testing practices, safe blood handling and storage, hemovigilance and adverse event reporting, workforce training, and stronger coordination across national and regional blood transfusion services. Because it is a cooperative agreement, continued funding would typically be tied to agreed workplans, performance monitoring, reporting requirements, and close collaboration with CDC technical staff to ensure that interventions align with national priorities and PEPFAR goals.

Overall, the key takeaway is that this is a CDC/PEPFAR continuation cooperative agreement meant to sustain and advance existing blood safety work in Kenya, and it is restricted to prior awardees from the earlier CDC-RFA-GH15-1545 program rather than being an open call for new organizations.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Supporting Implementation of Sustainable Blood Safety Activities in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-10-01.
• Applicants must submit their applications by 2015-12-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH15 154502CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: